| Financial Year |
March 31 2023 |
| Monetary Funds |
174,780,617.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
698,279,777.03 |
| Advances to Suppliers |
75,632,619.99 |
| Other Receivables |
9,609,851.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
475,592,966.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,594,471.73 |
| Total Current Assets |
1,577,133,481.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,838,201.50 |
| Investment Properties |
-- |
| Fixed Assetes |
369,664,470.50 |
| Under-construction Projects |
63,584,930.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
77,663,077.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
139,500.00 |
| Deferred Income Tax Assets |
20,058,824.16 |
| Other Non-Current Assets |
207,383,110.19 |
| Sub-Total of Non-Current Assets |
775,551,874.99 |
| Total Assets |
2,352,685,356.16 |
| Short-Term Loans |
488,238,420.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
210,000,000.00 |
| Accounts Payable |
136,390,184.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,799,155.91 |
| Taxes Payable |
24,913,640.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,251,279.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,526,096.77 |
| Other Current Liabilities |
1,727,147.31 |
| Sub-Total of Current Liabilities |
892,550,381.80 |
| Long-term Loans |
159,683,100.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,585,768.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,656,608.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
249,966,541.23 |
| Total Liabilities |
1,142,516,923.03 |
| Paid-In Capital(Or Share Stock) |
243,824,000.00 |
| Capital Surplus |
298,084,768.44 |
| Surplus Reserve |
58,828,145.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
546,952,933.25 |
| Minority Stockholder's Interest |
30,299,404.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,179,869,028.64 |
| Owner's Equity（Stockholder's Equity） |
1,210,168,433.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,352,685,356.16 |
